viewThe Valens Company

Valens GroWorks signs deal to supply Shoppers Drug Mart with cannabis oil products

The agreement makes Valens the first third-party processor to reach such a deal

Shoppers Drug Mart
The company will begin providing gel caps and tinctures to Medical Cannabis by Shoppers, one of the retailer’s e-commerce divisions

Valens GroWorks Corp (CVE:VGW) (OTCMKTS:VGWCF) has become the first third-party cannabis processor to reach a supply deal with Canadian pharmaceutical giant Shoppers Drug Mart. 

The company will begin providing gel caps and tinctures to Medical Cannabis by Shoppers, one of the retailer’s e-commerce divisions, according to a statement released Monday. In time, the deal is expected to expand to include vaporizer cartridges, topicals and other products. 

Valens said it would employ five unique extraction methods combined with its own intellectual property and formulation in order to create a wide breadth of products. 

READ: Valens GroWorks inks white label agreement to make cannabis-infused beverages

"Valens is proud to be chosen as the first third party extraction and product development company to supply cannabis oil products to one of the most recognized pharmacy retailers in Canada." CEO Tyler Robson said in a statement. 

“Our industry leading extraction, analytical testing and product formulation capabilities are ideally positioned to deliver the high quality, oil-based products and services expected from such a reputable industry leader such as Shoppers,” Robson said.

The Kelowna, British Columbia company’s various extraction services include CO2, Ethanol, Hydrocarbon, Solvent-less, and Terpene extraction.

Valens stock climbed 4.5% to C$3.72 on Bay Street on Monday and 4.9% to US$2.80 in New York.

—Updated to include stock movement—

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Quick facts: The Valens Company

Price: 2.04 CAD

Market: TSX
Market Cap: $261.12 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of The Valens Company named herein, including the promotion by the Company of The Valens Company in any Content on the Site, the Company receives...



The Valens Company is cashed up and ready to bring IP around the world

The Valens Company (CVE: VLNS- OTCQX: VLNCF) President Jeffrey Fallows joined Steve Darling from Proactive to discuss the company completing their rebrand. Fallows talks about what the new names mean for the future of the company. Fallows also shared details about a number of recent deals the...

on 25/6/20

2 min read